Smart Glasses, Lunar Logistics and Simpler Diabetes Care Offer a Compelling Growth Theme
Wall Street’s most interesting growth stories do not always share an industry. Sometimes they share a commercial breakthrough: making something difficult easier to buy, use or deliver. Warby Parker…
New Patient Research Strengthens the Case for MODD's Pivot
Medical technology often competes by adding features. Modular Medical (NASDAQ:MODD) is pursuing a different proposition: make insulin delivery less demanding for the people who must manage it every day. New patient research announced…
Healthcare’s most compelling growth stories often begin with an unglamorous proposition: make an existing problem less difficult to manage. For INOVIO Pharmaceuticals (NASDAQ: INO), that means a newly approved immunotherapy intended to reduce repeated surgeries. For IDEXX Laboratories (NASDAQ: IDXX), it means…
From SK hynix’s record results to Modular Medical’s European preparations, investors have more than one reason to look beyond interest-rate anxiety.
October 28, 2026
Wall Street does not need every company to thrive at once. It needs enough businesses to demonstrate that…
Beta Bionics, Inc. (NASDAQ: BBNX) has priced a $150 million public offering this week just as its product story is acquiring more commercial torque: FDA clearance for the Mint™ patch pump, a planned U.S. launch in the first quarter of 2027, and a…
Tenon Medical, Inc. (NASDAQ: TNON) is had the sort of trading day that causes even seasoned small-cap investors to refresh their screens twice. Shares closed up $5.96, or 109.36%, to $11.41, after hitting an intraday high of $16.28..Volume exceeded 48.4 million shares—roughly…
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has delivered the kind of Phase 3 result biotechnology investors wait patiently—and, on occasion, not so patiently—for. The company reported that avexitide reduced the composite rate of severe and clinically meaningful post-bariatric hypoglycemia events by 55% versus…
Heartflow, Inc. (NASDAQ: HTFL) is delivering the kind of growth story investors usually hope to find before it becomes obvious: rapid revenue expansion, rising gross margins, stronger adoption of a second product line, and a materially higher full-year outlook. In a market…
The diabetes-device sector is showing signs of a more interesting ailment for Wall Street: a shortage of skepticism. Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is pairing renewed financial discipline with product expansion, while Modular Medical, Inc. (NASDAQ: MODD) is taking its Pivot…
